Verona Pharma plc (VRP.L) (LON:VRP – Get Free Report) passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 55 ($0.69) and traded as low as GBX 50 ($0.63). Verona Pharma plc (VRP.L) shares last traded at GBX 55 ($0.69), with a volume of 70,791 shares traded.
Verona Pharma plc (VRP.L) Price Performance
The stock has a 50 day simple moving average of GBX 55 and a two-hundred day simple moving average of GBX 55. The company has a market cap of £228.00 million and a price-to-earnings ratio of -1.68. The company has a debt-to-equity ratio of 6.85, a current ratio of 2.99 and a quick ratio of 2.47.
Verona Pharma plc (VRP.L) Company Profile
Verona Pharma plc, a clinical stage biopharmaceutical company, develops and commercializes therapeutics to treat respiratory diseases. The company's product candidate is RPL554, an inhaled dual inhibitor of the enzymes phosphodiesterase 3 and 4, which has completed Phase I and II clinical trials that acts as a bronchodilator and an anti-inflammatory agent for the treatment of chronic obstructive pulmonary disease, cystic fibrosis, chronic asthma, and allergic rhinitis.
Featured Stories
- Five stocks we like better than Verona Pharma plc (VRP.L)
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- 3 CEO-Led Turnaround Stocks You Can Still Buy
- How to Calculate Return on Investment (ROI)
- 3 Value Stocks You Can Buy Before They Become Big
- What is a Low P/E Ratio and What Does it Tell Investors?
- Chinese Stocks Stage Impressive Rebound
Receive News & Ratings for Verona Pharma plc (VRP.L) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verona Pharma plc (VRP.L) and related companies with MarketBeat.com's FREE daily email newsletter.